In the evolving field of biochemical research, specific sequences often capture the interest of those exploring cellular interactions. One such sequence is the 4N1K peptide, a molecule that has become a subject of significant inquiry within laboratory settings. For those of us dedicated to studying molecular biology, understanding the nuance of such compounds—and how they function i 4N1K peptide n controlled environments—is essential.
What is the 4N1K Peptide?
At its core, the 4N1K peptide is a biologically active peptide with the specific sequence KRFYVVMWKK. It is widely recognized as a 10-mer peptide derived from the C-terminal, globular domain of thrombospondin-1 (TSP-1) and TSP-2. Because 4N1K is a cell-binding domain adhesive peptide, it serves as a critical tool for researchers investigating signal transduction and cell-to-cell adhesion mechanisms.
From a structural perspective, the chemical formula of this compound is C68H105N17O12S (CID 9989085). Its unique configuration allows it to interact with various cellular receptors, which is why it is frequently utilized in experiments focused on modulating integrin function.
Research Observations and Experimental Context
When examining the literature, it becomes clear that 4N1K peptide is a biological active peptide with diverse roles. One of the most documented areas of study involves its interaction with cell surface receptors. For instance, observations have noted that 4N1K had significant CD47-independent effects, which is a vital distinction for researchers aiming to isolate specific pathways without the interference of CD47 signaling.
Comparative Studies: PKHB1 and 4N1K
In many laboratory protocols, scholars often compare peptide analogues PKHB1 and 4N1K to better understand thei 4N1K peptide r specific binding affinities. There is documented evidence that PKHB1 and 4N1K promote antibody binding to CD47−/− Jurkat and MOLT4 cell lines, providing a clearer picture of how these molecules operate in non-traditional environments.
Investigating Cellular Responses
My interest in this area stems from how these peptides influence cellular behavior. For example, when Jurkat cells with 4N1K ar Peptide analogues PKHB1 and 4N1K induce cell deaththrough CD47‐independent mechanisms. Cancer Science - United States. e incubated under specific conditions, the resulting cellular aggregate formation suggests that the concentration of the peptide is a major variable in the outcome. Furthermore, the 4N1K-related peptides are often tested to determine whether they can influence the aggregation and spreading of platelets on immobilized collagen, specifically in cells expressing IAP (Integrin-Associ 4N1K-peptide derived from thrombospondins acts as a tumour ated Protein).
Potential Applications in Scientific Inquiry
The scientific community has long noted that the 4N1K-peptide derived from thrombospondins acts as a tumour suppressor in bladder cancer models, both *in vivo* and *in vitro*. This has led to extensive mapping of how the 4N1K-peptide interacts with the extracellular matrix.
It is important to note for those new to this research that 4N1K is a tool intended strictly for laboratory use. When conducting these experiments, the focus remains on:
* Signal Transduction: Analyzing how the peptide influences internal cell communication.
* Adhesion Studies: Utilizing the peptide to observe cell-binding behaviors.
* Integrin Modulation: Understanding how the C-terminal domain of TSP-1 influences structural integrity.
Concluding Thoughts on the 4N1K Peptide
Whether you are looking at how the 4N1K peptide infl Thrombospondin-1-derived 4N1K peptide expression is uences tube formation or exploring why it has anti-cancer activities in several cancers, the precision of your methodology is paramount. This sequen Thrombospondin-1-derived 4N1K peptide expression is ce continues to be a corn Peptide analogues PKHB1 and 4N1K induce cell deaththrough CD47‐independent mechanisms. Cancer Science - United States. erstone for those investigating the PKHB1 and 4N1K promote antibody binding to CD47−/− Jurkat and MOLT4.. Peptide analogues PKHB1 and 4N1K induce cell death through CD47‐independent mechanisms. complex interplay between thrombospondin-derived fragments and cellular receptors.
As with any specialized reagent, the key to successful research lies in the consistency of the peptide's purity and the rigor of the experimental design. By focusing on the specific biochemical properties of this 10-mer sequence, researchers can continue to uncover the intricate mechanisms that govern cell adhesion and signaling.
***
*Disclaimer: This article is for informational purposes for research professionals only. The compounds discussed are for in vitro research use and are not for human or clinical consumption.*